TECHNOLOGY LICENSING OPPORTUNITY: NanoFET
ENERGY, DEPARTMENT OF
Place of performance: Los Alamos, NM
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 18, 2026
- Closes
- Dec 18, 2026 (in 137 days)
Similar opportunities open now
- TECHNOLOGY LICENSING OPPORTUNITY: NanoFETOpenENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs PlatformOpenENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics PlatformOpenENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphProOpenENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: ScreenFlow Liquid-Liquid MicrocontactorOpenENERGY, DEPARTMENT OFNo deadline listed
At a glance
This is a government contract opportunity posted by ENERGY, DEPARTMENT OF in the research and development in biotechnology (except nanobiotechnology) category. The deadline is December 18, 2026, 137 days from now. Work is performed in Los Alamos, NM.
Classification and identifiers
- Industry (NAICS)
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- Product or service (PSC)
- General Science and Technology R&D Services; General Science and Technology; Applied Research (AJ12)
- Solicitation number
- S-194657
- Contracting office
- TRIAD - DOE CONTRACTOR
Who can apply
No Set aside used. NONE
About this opportunity
NanoFiber Engineered Therapeutics Platform (NanoFET) from Los Alamos National Laboratory offers pharmaceutical and biodefense organizations a modular, adaptable scaffold for building next-generation immunotherapies. By merging self-assembling peptide nanofibers with interchangeable nanobody and peptide components, the platform enables rapid development of targeted treatments that bridge disease agents directly to the patient’s own immune cells. Infectious diseases and chronic conditions such as cancer continue to impose enormous public health and economic burdens worldwide. Conventional vaccines and biologics are typically designed against a single pathogen or target, leaving populations vulnerable when new or unknown threats emerge. For military personnel and first responders, the absence...
Related opportunities
- TECHNOLOGY LICENSING OPPORTUNITY: NanoFETENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs PlatformENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs PlatformENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics PlatformENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphProENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: ScreenFlow Liquid-Liquid MicrocontactorENERGY, DEPARTMENT OF